Karyopharm Therapeutics Cash from Financing (TTM) Insights

Karyopharm Therapeutics Inc (KPTI)

1.145 -0.13 (-10.20%) USD | NASDAQ | Apr 19, 15:51

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	1.124M
September 30, 2023	156.70M
June 30, 2023	162.50M
March 31, 2023	162.96M
December 31, 2022	193.74M
September 30, 2022	38.79M
June 30, 2022	33.01M
March 31, 2022	93.76M
December 31, 2021	73.65M
September 30, 2021	76.72M
June 30, 2021	77.94M
March 31, 2021	17.93M
December 31, 2020	172.08M
September 30, 2020	203.05M
June 30, 2020	290.63M
March 31, 2020	288.98M
December 31, 2019	124.30M
September 30, 2019	257.14M
June 30, 2019	169.10M
March 31, 2019	315.83M
December 31, 2018	316.11M

Date	Value
September 30, 2018	171.29M
June 30, 2018	170.68M
March 31, 2018	76.12M
December 31, 2017	75.74M
September 30, 2017	72.04M
June 30, 2017	103.35M
March 31, 2017	51.02M
December 31, 2016	51.16M
September 30, 2016	33.40M
June 30, 2016	1.959M
March 31, 2016	1.736M
December 31, 2015	92.70M
September 30, 2015	91.36M
June 30, 2015	204.66M
March 31, 2015	204.27M
December 31, 2014	113.12M
September 30, 2014	226.13M
June 30, 2014	156.97M
March 31, 2014	180.41M
December 31, 2013	185.93M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.124M

Minimum

Dec 2023

290.63M

Maximum

Jun 2020

136.53M

Average

156.70M

Median

Sep 2023

Cash from Financing (TTM) Benchmarks